You can buy or sell VolitionRX and other stocks, options, ETFs, and crypto commission-free!
VolitionRX Limited Common Stock, also called VolitionRX, is a multi-national life sciences company. It engages in the development of blood-based cancer tests to help diagnose a range of cancers. Read More Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.
Singapore, Central Singapore
52 Week High
52 Week Low
Seeking AlphaMar 14
VolitionRX Ltd. (VNRX) CEO Cameron Reynolds on Q4 2018 Results - Earnings Call Transcript
VolitionRX Ltd. (NYSEMKT:VNRX) Q4 2018 Earnings Conference Call March 14, 2019 8:30 AM ET Company Participants Scott Powell - EVP, IR Cameron Reynolds - President & CEO Conference Call Participants Mark Breidenbach - Oppenheimer Jason McCarthy - Maxim Group Bruce Jackson - The Benchmark Company Brian Marckx - Zacks Investment Research Operator Good morning ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2018 Earnings Conference Cal...
-$0.13 per share
-$0.11 per share